Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The FTX transcript, encoded by ENSG00000278421, is a long non-coding RNA that contains a region highly conserved in the regulation of XIST, which plays a role in X chromosome inactivation in eukaryotes[1][3]. As a non-coding RNA, it is not a protein nor a typical therapeutic target and is not currently linked to drug action, disease indications, or clinical biomarker use. Its main recognized function is epigenetic regulation, specifically acting as a positive regulator of XIST expression—a process essential for the regulation of gene dosage in female mammals. No evidence is available for its involvement in direct disease associations, drug interaction, or utility as a biomarker. The entry does not correspond to a classical drug target and should be marked as incorrect for contexts expecting a therapeutic drug target molecule such as a receptor or enzyme[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FTX transcript, XIST regulator conserved region 1 (FTX).